What is NDC 62332-812?

62332-812 is the product NDC for Triamcinolone Acetonide, Triamcinolone acetonide 40 mg/mL injection, suspension, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Triamcinolone Acetonide?

220 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Triamcinolone Acetonide NDC 62332-812 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-812Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0812Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-812-01	62332081201	1 VIAL, SINGLE-DOSE in 1 CARTON (62332-812-01) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 17, 2025
62332-812-25	62332081225	25 VIAL, SINGLE-DOSE in 1 CARTON (62332-812-25) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 17, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamcinolone Acetonide
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — 40 mg/mL
Dosage form: Injection, Suspension
Route: Intra-articular, Intramuscular
Labeler: Alembic Pharmaceuticals Inc.NDC labeler code 62332
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218601
Marketing start: Oct 17, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 62332-812_6669782e-f36e-4625-879a-155b8fb814caSPL ID 6669782e-f36e-4625-879a-155b8fb814caSPL set ID 05c2a9cf-a018-48c0-9c73-2d59d52211d2RxCUI 1085754, 1792144UNII F446C597KA
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N462332081201 followed by a unit qualifier and the quantity

Package 62332-0812-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 3, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62332-812

What is NDC 62332-812?: 62332-812 is the product NDC for Triamcinolone Acetonide, Triamcinolone acetonide 40 mg/mL injection, suspension, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Triamcinolone Acetonide.
What is the active ingredient?: Triamcinolone acetonide.
Who is the labeler?: Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Triamcinolone Acetonide?: 220 other product NDCs are listed under this name. See all Triamcinolone Acetonide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Triamcinolone Acetonide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Triamcinolone Acetonide	Triamcinolone acetonide 55 ug/1	Spray, MeteredNasal	Aurohealth LLC	58602-035	58602-0035-0758602-0035-0858602-0035-09+1 more
Triamcinolone Acetonide	Triamcinolone acetonide .25 mg/g	CreamTopical	Preferred Pharmaceuticals Inc.	68788-4148	68788-4148-01
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	CreamTopical	Direct_rx	72189-670	72189-0670-30
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	CreamTopical	Direct_Rx	61919-234	61919-0234-3061919-0234-80
Triamcinolone Acetonide	Triamcinolone acetonide 400 mg/10mL	Injection, SuspensionIntra-articular, Intramuscular	REMEDYREPACK INC.	70518-4582	70518-4582-00
Triamcinolone Acetonide	Triamcinolone acetonide 40 mg/mL	Injection, SuspensionIntra-articular, Intramuscular	Sagent Pharmaceuticals	25021-054	25021-0054-0125021-0054-0525021-0054-10
Triamcinolone acetonide	Triamcinolone acetonide 5 mg/g	OintmentTopical	REMEDYREPACK INC.	70518-4546	70518-4546-00
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	CreamTopical	REMEDYREPACK INC.	70518-4527	70518-4527-00
Triamcinolone Acetonide	Triamcinolone acetonide 55 ug/1	Spray, MeteredNasal	CARDINAL HEALTH 110, LLC. DBA LEADER 70000	70000-0742	70000-0742-01
Triamcinolone Acetonide	Triamcinolone acetonide 40 mg/mL	Injection, SuspensionIntra-articular, Intramuscular	Dr. Reddy's Laboratories Inc	43598-677	43598-0677-1143598-0677-25

All 221 Triamcinolone Acetonide NDCs

Other NDCs under ANDA 218601

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218601
Product	Strength	Form · route	Labeler	Product NDC
Triamcinolone Acetonide	Triamcinolone acetonide 40 mg/mL	Injection, SuspensionIntra-articular, Intramuscular	Alembic Pharmaceuticals Limited	46708-812
Triamcinolone Acetonide	Triamcinolone acetonide 200 mg/5mL	Injection, SuspensionIntra-articular, Intramuscular	Alembic Pharmaceuticals Limited	46708-090
Triamcinolone Acetonide	Triamcinolone acetonide 400 mg/10mL	Injection, SuspensionIntra-articular, Intramuscular	Alembic Pharmaceuticals Limited	46708-091
Triamcinolone Acetonide	Triamcinolone acetonide 200 mg/5mL	Injection, SuspensionIntra-articular, Intramuscular	Alembic Pharmaceuticals Inc.	62332-090
Triamcinolone Acetonide	Triamcinolone acetonide 400 mg/10mL	Injection, SuspensionIntra-articular, Intramuscular	Alembic Pharmaceuticals Inc.	62332-091
Triamcinolone Acetonide	Triamcinolone acetonide 40 mg/mL	Injection, SuspensionIntra-articular, Intramuscular	Sagent Pharmaceuticals	25021-054